JNJ 19567470

Drug Profile

JNJ 19567470

Alternative Names: CRA 5626; JNJ 19567470; R 317573

Latest Information Update: 18 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Janssen Pharmaceutica; Taisho Pharmaceutical
  • Class Antidepressants; Anxiolytics; Piperidines; Pyrimidines
  • Mechanism of Action Corticotropin releasing factor receptor 1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Anxiety disorders; Depressive disorders; Panic disorder

Most Recent Events

  • 08 Aug 2017 Discontinued - Phase-II for Anxiety disorders (in volunteers) in Netherlands (PO)
  • 08 Aug 2017 Discontinued - Phase-II for Anxiety disorders (in volunteers) in United Kingdom (PO)
  • 08 Aug 2017 Discontinued - Phase-II for Depressive disorders (in volunteers) in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top